Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button

Home > News > Dabur Pharma's Nanoxel receives DCGI approval

February 21st, 2008

Dabur Pharma's Nanoxel receives DCGI approval

Abstract:
Dabur Pharma announced that the Drug Controller General of India (DCGI) has approved its proprietary nanoparticle Paclitaxel formulation ‘Nanoxel' for additional indications of ovarian cancer, non-small cell lung cancer and AIDS related Kaposis's sarcoma. Speaking on the occasion Ajay Kumar Vij, CEO, Dabur Pharma said, "We are very pleased by DCGI's decision. Consistent with our mission of making cancer therapy available to more people, this approval will help a much larger patient population have access to a significantly safer and more convenient therapeutic alternative to conventional Paclitaxel." Nanoxel is a cremophor free polymeric nanoparticle formulation of Paclitaxel with no hypersensitivity reactions, which allows administration to patients without cumbersome pre-medication as is required with cremophor Paclitaxel.

Source:
expresspharmaonline.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Dirty to drinkable: Engineers develop novel hybrid nanomaterials to transform water July 28th, 2016

Thomas Swan and NGI announce unique partnership July 28th, 2016

Penn team uses nanoparticles to break up plaque and prevent cavities July 28th, 2016

Beating the heat a challenge at the nanoscale: Rice University scientists detect thermal boundary that hinders ultracold experiments July 28th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Thomas Swan and NGI announce unique partnership July 28th, 2016

Penn team uses nanoparticles to break up plaque and prevent cavities July 28th, 2016

Beating the heat a challenge at the nanoscale: Rice University scientists detect thermal boundary that hinders ultracold experiments July 28th, 2016

Enhancing molecular imaging with light: New technology platform increases spectroscopic resolution by 4 fold July 27th, 2016

Nanomedicine

Starpharma initiates new DEP™ drug delivery program with AstraZeneca July 27th, 2016

Scientists test nanoparticle drug delivery in dogs with osteosarcoma July 26th, 2016

The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins July 26th, 2016

Accurate design of large icosahedral protein nanocages pushes bioengineering boundaries: Scientists used computational methods to build ten large, two-component, co-assembling icosahedral protein complexes the size of small virus coats July 25th, 2016

Announcements

Dirty to drinkable: Engineers develop novel hybrid nanomaterials to transform water July 28th, 2016

Thomas Swan and NGI announce unique partnership July 28th, 2016

Penn team uses nanoparticles to break up plaque and prevent cavities July 28th, 2016

Beating the heat a challenge at the nanoscale: Rice University scientists detect thermal boundary that hinders ultracold experiments July 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic